tuberculosis
play

TUBERCULOSIS IN NEW YORK CITY, 2017 New York City Bureau of - PowerPoint PPT Presentation

Sep 25, 2022 •188 likes •468 views

TUBERCULOSIS IN NEW YORK CITY, 2017 New York City Bureau of Tuberculosis Control TUBERCULOSIS CASES AND RATES, 1 NEW YORK CITY, 1983-2017 Number of cases Rate 4500 60 4000 50 3500 Rate per 100,000 Number of cases 3000 40 2500 7.5 per

  1. TUBERCULOSIS IN NEW YORK CITY, 2017 New York City Bureau of Tuberculosis Control

  2. TUBERCULOSIS CASES AND RATES, 1 NEW YORK CITY, 1983-2017 Number of cases Rate 4500 60 4000 50 3500 Rate per 100,000 Number of cases 3000 40 2500 7.5 per 100,000 30 2000 613 cases 1500 20 1000 10 500 0 0 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 Year 1. Rates are based on decennial Census data

  9. Bolivia Haiti

  26. INFOGRAPHICS, MAPS, AND HARD COPIES OF THE ANNUAL TB SUMMARY ARE AVAILABLE Online: nyc.gov/health/tb Hard copies: Email tb-epi@health.nyc.gov

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

What you need to know James Zoretic M.D., M.P.H. Regions 2 and 3 Director What is Tuberculosis?

What you need to know James Zoretic M.D., M.P.H. Regions 2 and 3 Director What is Tuberculosis?

Tuberculosis What you need to know James Zoretic M.D., M.P.H. Regions 2 and 3 Director What is Tuberculosis? Tuberculosis, (TB) is a communicable disease caused by the Mycobacterium tuberculosis bacillus Slow growing germ Spread by

635 views • 29 slides
What you need to know James Zoretic M.D., M.P.H. Regions 2 and 3 Director What is Tuberculosis?

What you need to know James Zoretic M.D., M.P.H. Regions 2 and 3 Director What is Tuberculosis?

Tuberculosis What you need to know James Zoretic M.D., M.P.H. Regions 2 and 3 Director What is Tuberculosis? Tuberculosis, (TB) is a communicable disease caused by the Mycobacterium tuberculosis bacillus Slow growing germ Spread by

654 views • 30 slides
Tuberculosis in the United States 1993 2018* National Tuberculosis Surveillance System

Tuberculosis in the United States 1993 2018* National Tuberculosis Surveillance System

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination Tuberculosis in the United States 1993 2018* National Tuberculosis Surveillance System *Updated as of June 6, 2019 Reported

678 views • 45 slides
P RIS Bettencourt TUBERCULOSIS IS A WORLDWIDE DISEASE 1 3 OF THE WORLD POPULATION HAS

P RIS Bettencourt TUBERCULOSIS IS A WORLDWIDE DISEASE 1 3 OF THE WORLD POPULATION HAS

P RIS Bettencourt TUBERCULOSIS IS A WORLDWIDE DISEASE 1 3 OF THE WORLD POPULATION HAS LATENT TUBERCULOSIS MILLION 1.3 DEATHS PER YEAR FIGHT TUBERCULOSIS MODERN WEAPONS with target detect infjltrate sabotage gender study INFILTRATE

725 views • 38 slides
Florida, 2016 Tuberculosis Control Section Division of Disease Control and Health Protection

Florida, 2016 Tuberculosis Control Section Division of Disease Control and Health Protection

Tuberculosis Florida, 2016 Tuberculosis Control Section Division of Disease Control and Health Protection 4052 Bald Cypress Way, Bin A-20 Tallahassee, FL 32399 http://www.floridahealth.gov/diseases-and-conditions/tuberculosis Division of

491 views • 14 slides
Technological & Financial Analysis of a Carbohydrate Vaccine for Tuberculosis Presented by:

Technological & Financial Analysis of a Carbohydrate Vaccine for Tuberculosis Presented by:

Technological & Financial Analysis of a Carbohydrate Vaccine for Tuberculosis Presented by: Melissa Martin Erica Clemente-Harl Tuberculosis Currently: Projected: ! Leading cause of death in ! 37,800,000 of current HIV developing world

1.2k views • 71 slides
Introduction Excluding HIV/AIDS, Tuberculosis (TB) is responsible for more deaths worldwide than

Introduction Excluding HIV/AIDS, Tuberculosis (TB) is responsible for more deaths worldwide than

Tuberculosis: the hidden disease Introduction Excluding HIV/AIDS, Tuberculosis (TB) is responsible for more deaths worldwide than any other infectious agent, with approximately 1.4 million global mortalities in 2011 (WHO, 2012). Although TB

579 views • 23 slides
After more than one decade of the epoch making discovery of the tuberculosis agent and more than

After more than one decade of the epoch making discovery of the tuberculosis agent and more than

After more than one decade of the epoch making discovery of the tuberculosis agent and more than fifty years of the introduction of the efficient antituberculotics, tuberculosis is still the leading agent for the mortality among adults all

347 views • 19 slides
CONTROL PROFESSIONAL Alawode Oladele, MD, MPH Elements of our Tuberculosis Control Program X-ray

CONTROL PROFESSIONAL Alawode Oladele, MD, MPH Elements of our Tuberculosis Control Program X-ray

TUBERCULOSIS FOR THE INFECTION CONTROL PROFESSIONAL Alawode Oladele, MD, MPH Elements of our Tuberculosis Control Program X-ray Targeted testing/ LTBI treatment Pharmacy Clinical Inpatient care Medical evaluation Services and follow-up

763 views • 34 slides
Showcasing some research in Genomics and Bioinformatics Sacchettini Lab: Research Tuberculosis

Showcasing some research in Genomics and Bioinformatics Sacchettini Lab: Research Tuberculosis

Showcasing some research in Genomics and Bioinformatics Sacchettini Lab: Research Tuberculosis What is it? Tuberculosis (TB) is an infectious disease caused by a bacterium. Approximately two billion people, one third of the Earth's

410 views • 14 slides
Improved diagnosis of extrapulmonary tuberculosis by antigen detection using

Improved diagnosis of extrapulmonary tuberculosis by antigen detection using

Improved diagnosis of extrapulmonary tuberculosis by antigen detection using immunochemistry-based assay Tehmina Mustafa Overview Introduction: extrapulmonary tuberculosis (TB) & diagnostic challenges New diagnostic method

362 views • 25 slides
Mycobacterium tuberculosis Mycobacterium tuberculosis Rv2224c modulates innate Rv2224c modulates

Mycobacterium tuberculosis Mycobacterium tuberculosis Rv2224c modulates innate Rv2224c modulates

Mycobacterium tuberculosis Mycobacterium tuberculosis Rv2224c modulates innate Rv2224c modulates innate immune responses immune responses Jyothi Rengarajan, Elissa Murphy, Arnold Park, Arnold Park, Cassandra L. Krone, Erik C. Hett, Barry R.

616 views • 37 slides
1 Scanning electron micrograph of Mycobacterium tuberculosis 2 3 Sarah Stanley Deb Hung 4

1 Scanning electron micrograph of Mycobacterium tuberculosis 2 3 Sarah Stanley Deb Hung 4

Brain Blood vessels Lungs Heart Pancreas Liver Kidney Cartilage Bone Muscle 1 Scanning electron micrograph of Mycobacterium tuberculosis 2 3 Sarah Stanley Deb Hung 4 1.7 million deaths/year Tuberculosis 9.2 million new

439 views • 16 slides
Changing the Conversation: Human Rights and the Power of Words in Tuberculosis Care July 16,

Changing the Conversation: Human Rights and the Power of Words in Tuberculosis Care July 16,

Changing the Conversation: Human Rights and the Power of Words in Tuberculosis Care July 16, 2015 Sponsored by Global Tuberculosis Institute Rutgers, The State University of New Jersey Housekeeping Faculty Jane Carter, MD President, The

687 views • 36 slides
Tuberculosis in Nunavut, Canada Dora Maria Carbonu, EdD, MN, RN 24 th Sigma Theta Tau

Tuberculosis in Nunavut, Canada Dora Maria Carbonu, EdD, MN, RN 24 th Sigma Theta Tau

Tuberculosis in Nunavut, Canada Dora Maria Carbonu, EdD, MN, RN 24 th Sigma Theta Tau International Nursing Research Congress Prague, Czech Republic July 22 26, 2013 TUBERCULOSIS IN NUNAVUT, CANADA One Community's Initiative To Promote

733 views • 48 slides
Tuberculosis in Primary Care April 22, 2015 ADVANCES IN INFECTIOUS DISEASES Julie Higashi, MD,

Tuberculosis in Primary Care April 22, 2015 ADVANCES IN INFECTIOUS DISEASES Julie Higashi, MD,

4/22/15 Tuberculosis in Primary Care April 22, 2015 ADVANCES IN INFECTIOUS DISEASES Julie Higashi, MD, PhD TB Controller, San Francisco DPH Assistant Clinical Professor of Medicine UCSF, Curry International Tuberculosis Center 1 Disclosure

540 views • 31 slides
ACADEMIC CHALLENGE Another bout of team activities sent the Middle school students through

ACADEMIC CHALLENGE Another bout of team activities sent the Middle school students through

Issue 14, Nov. 16, 2007 THOUGHT FOR THE DAY The first step in the acquisition of wisdom is silence, the second listening, the third memory, the fourth practice, the fifth teaching others. Solomon Ibn Gabriol ACADEMIC CHALLENGE Another bout

175 views • 4 slides
Pacing/Teacher's Notes Investigation #6: Cellular Respiration Click on the topic to go to that

Pacing/Teacher's Notes Investigation #6: Cellular Respiration Click on the topic to go to that

Slide 1 / 36 Slide 2 / 36 New Jersey Center for Teaching and Learning AP BIOLOGY Progressive Science Initiative This material is made freely available at www.njctl.org and is intended for the non-commercial use of Investigation #6 students

247 views • 6 slides
Refugee and asylum seeker health Refugee Health Fellow Program March 2018 do not use after

Refugee and asylum seeker health Refugee Health Fellow Program March 2018 do not use after

Refugee and asylum seeker health Refugee Health Fellow Program March 2018 do not use after June 2018 Legal status Refugee: Someone who, owing to a well founded fear of being persecuted for reasons of race, religion, nationality,

270 views • 22 slides
Acetylation of the chalcone yields 2- Acetoxy-3,4-dimethoxy-5-methyl chalcone (VIII). The

Acetylation of the chalcone yields 2- Acetoxy-3,4-dimethoxy-5-methyl chalcone (VIII). The

[c024] Synthesis and anti-microbial screening of 3-(3,4-Dimethoxyphenyl)-1-(2-hydroxy-5- methylphenyl)prop-2-en-one and its heterocyclic analogs. Arshi Naqvi*, Mohd. Shahnawaaz, Arikatla V. Rao and Daya S. Seth School of Chemical Sciences,

247 views • 11 slides
Tuberculosis Recommended Queries NCHHSTP Atlas National Center for HIV/AIDS, Viral Hepatitis, STD

Tuberculosis Recommended Queries NCHHSTP Atlas National Center for HIV/AIDS, Viral Hepatitis, STD

Tuberculosis Recommended Queries NCHHSTP Atlas National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention The NCHHSTP Atlas is an online, interactive tool that gives you the power to analyze, map, and create tables using HIV, STD, viral

90 views • 6 slides
ReBaStaBa : handling Bayesian Network with R Jean-Baptiste.Denis@Jouy.Inra.Fr

ReBaStaBa : handling Bayesian Network with R Jean-Baptiste.Denis@Jouy.Inra.Fr

UseR'09 09_07_09 1/17 ReBaStaBa : handling Bayesian Network with R Jean-Baptiste.Denis@Jouy.Inra.Fr ML.Delignette@Vet-Lyon.Fr RPouillot@yahoo.Fr UseR'09 PLAN 09_07_09 2/17 Bayesian Network Defining a Bayesian Network [/bn/]

474 views • 18 slides
This presentation summaries the health pathways for refugee and asylum seeker children in

This presentation summaries the health pathways for refugee and asylum seeker children in

This presentation summaries the health pathways for refugee and asylum seeker children in Victoria. The areas covered include health screening, access to health care and specific health pathways. 1 2 3 There are many different areas that

383 views • 34 slides
Travelling securely on the Grid to the origin of the Universe F-Secure SPECIES 2007 conference

Travelling securely on the Grid to the origin of the Universe F-Secure SPECIES 2007 conference

Travelling securely on the Grid to the origin of the Universe F-Secure SPECIES 2007 conference Wolfgang von Rden 1 Head, IT Department, CERN, Geneva 24 January 2007 1 Zurich January 2007 CERN stands for over 50 years of

701 views • 43 slides

More recommend